Open AccessRecurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in patients with ANCA-associated vasculitis and COVID-19
Author(s) -
M. Mbengue,
Bede Bigirimana,
Lolly Romeo Irankunda,
Mohamed Cherif Dial,
Abdou Niang
Publication year - 2022
Publication title -
clinical nephrology - case studies
Language(s) - English
Resource type - Journals
ISSN - 2196-5293
DOI - 10.5414/cncs110567
Subject(s) - medicine , hydroxychloroquine , vasculitis , cyclophosphamide , context (archaeology) , immunology , tocilizumab , covid-19 , immune system , immunosuppression , disease , chemotherapy , infectious disease (medical specialty) , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom